News Posts List
The Role of Medical Liability Reform in Federal Health Care Reform
06/15/2009
Medical liability reform has garnered relatively little attention in the past two congressional sessions in striking contrast to its prominence in previous federal health policy debates. The ebbing of the recent malpractice insurance "crisis" may have undercut momentum for liability reform, but a more important explanation relates to the politics of the issue.
Study finds molecules that cause cancer pain
06/15/2009
German scientists found that the pain experienced by cancer patients might be attributed to a hormonelike molecule created by tumors.
Men More Likely To Die Of Cancer Than Women
06/15/2009
They are also around 70% more likely to die from cancers that affect both men and women, such as stomach, liver and kidney cancer. Skip related content.
My kidney cancer diary
06/15/2009
My cancer journey first started when a lump appeared on my chest in November 2007.
Dying patients who demand drugs on NHS labelled 'blinkered'
06/13/2009
Prof David Barnett, the chairman of the National Institute for health and Clinical Excellence's (Nice) appraisal committee, which decides if drugs can be prescribed on the NHS, also compared receiving the medications to buying a luxury car.
Meet the Expert: Robert J. Motzer, MD
06/13/2009
On a national level, Dr. Motzer works to improve the quality and delivery of cancer care for individuals diagnosed with kidney cancer and testicular cancer through his healthcare policy and advocacy activities. He chairs the National Comprehensive Care Network Kidney Cancer and Testicular Cancer Guidelines Panel. He also serves on the Medical Advisory Board for the Kidney Cancer Association, a charitable organization comprised of patients, family members, physicians, and researchers dedicated to kidney cancer patient advocacy.
Sen. McConnell: Government-run health reform plan is bad
06/13/2009
Last summer, the board in Great Britain denied patients in that country access to four kidney cancer drugs that have the potential to extend life. Heres the chilling explanation it gave to justify the move: Quote: Although these treatments are clinically effective, regrettably the cost is such that they are not a cost-effective use of resources. After a public outcry, NICE reversed its position on one of the drugs, but reaffirmed its ban on the other three.
Counterfeit Drug Information for Kidney Cancer Patients
06/13/2009
In today's global environment, it doesn't matter if you live in United States, Europe, Asia, or Africaeveryone is at risk from unsafe drugs. Counterfeit drugs defraud consumers and deny patients therapies that can alleviate suffering and save lives. Unfortunately, in some cases, these drugs have caused great harm and fatalities.
Top Abstracts in Renal Cancer
06/12/2009
The abstracts most highly rated/most read by nearly 300,000 physicians. Over 2000 peer-reviewed journals are covered by TopAbstracts.
LIFT FOR LIFE | Paterno, Clark & Lee Meet With Media
06/12/2009
One of the highlights of the second summer session will include Penn State Uplifting Athletes' Lift for Life, raising contributions for the Kidney Cancer Association. The seventh annual event is set for Friday, July 10 from 2-7 p.m. in Holuba Hall. Members of the Nittany Lion football team have raised more than $300,000 to assist kidney cancer patients and improve awareness of the disease the past six years. The Penn State Lift for Life is open to the public.
News Feed